Two Sigma Investments
BIVI icon

Two Sigma Investments’s BioVie BIVI Stock Holding History

Two Sigma Investments’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,412
Closed -$24.8K – 4591
2025
Q4 		$24.8K Sell
21,412
-11,093
-34% -$17.9K ﹤0.01% 3983
2025
Q3 		$61.8K Buy
+32,505
New +$132K ﹤0.01% 3524
2025
Q2 		– Sell
-2,161
Closed -$21.2K – 3193
2025
Q1 		$21.2K Sell
2,161
-710
-25% -$11.4K ﹤0.01% 3097
2024
Q4 		$57.4K Buy
+2,871
New +$69.2K ﹤0.01% 3029
2024
Q3 		– Sell
-140
Closed -$5.63K – 3121
2024
Q2 		$5.63K Buy
+140
New +$6.7K ﹤0.01% 2975

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Two Sigma Investments's BIVI Position: Q1 2026 in Review

Two Sigma Investments sold out of BioVie (BIVI) in Q1 2026, closing a stake of 21,412 shares — an estimated $24.8K sold.

Two Sigma Investments first reported a position in BIVI in Q2 2024 and held it in 5 quarters. The position peaked at $61.8K in Q3 2025. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • Two Sigma Investments reported no remaining BioVie position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 21,412 BioVie shares in Q1 2026, an estimated $24.8K.
  • Two Sigma Investments first reported a position in BioVie in Q2 2024 and held it in 5 quarters.
  • Two Sigma Investments's BioVie position peaked at $61.8K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.